Publications

Publications

Filter Results: (187) Arrow Down

Show Results For

← Page 9 of 187 Results →
Sort by

Are you looking for?

→Search All HBS Web
  • 08 May 2012
  • First Look

First Look: May 8

case updates events since the court's ruling against Myriad Genetics on March 29, 2010, and should be used in conjunction with "Gene Patents (A)." On July 29, 2011, a U.S. appeals court reversed the prior ruling against Myriad.... View Details
Keywords: Carmen Nobel
  • 12 Aug 2008
  • First Look

First Look: August 12, 2008

Commercializing a Diagnostic Test Harvard Business School Case 308-090 What are the barriers and opportunities to commercializing genetic diagnoses for disease? Purchase the case:... View Details
Keywords: Sean Silverthorne
  • 06 Feb 2007
  • First Look

First Look: February 6, 2007

Industry Harvard Business School Case 507-021 ViaGen has invested heavily to develop cloning technology for the livestock industry. Cloning has the potential to significantly improve the genetics of livestock, leading to higher quality... View Details
Keywords: Martha Lagace
  • 25 Apr 2005
  • Research & Ideas

New Learning at American Home Products

commercializing new biotechnology. This lack of technical capabilities led to two major acquisitions late in the twentieth century. In 1989 American Home Products acquired, for $666 million, 60 percent of the equity of the Genetics... View Details
Keywords: by Alfred D. Chandler Jr.; Chemical; Health; Manufacturing; Pharmaceutical
  • 07 Nov 2017
  • First Look

New Research and Ideas: November 7, 2017

for its commitment to improving health care outcomes and lowering costs by reducing treatment variation, made the surprising decision to invest significant resources in an innovative precision medicine unit, which would provide life-extending, View Details
Keywords: Carmen Nobel
  • 22 Nov 2016
  • First Look

November 22, 2016

and the University of California, Berkeley were in the middle of a contentious patent dispute over which entity controlled a breakthrough gene editing technology called CRISPR-Cas9. With CRISPR-Cas9, scientists might soon be able to cure previously incurable View Details
Keywords: Sean Silverthorne
  • 03 Aug 2010
  • First Look

First Look: August 3

  PublicationsLords of the Harvest: Symbolic Signaling and Regulatory Approval of Genetically Modified Organisms Authors:Shon R. Hiatt and Sangchan Park Publication:Best Paper Proceedings of the Academy of Management (2010) Abstract Firms... View Details
Keywords: Martha Lagace
  • 13 Jan 2009
  • First Look

First Look: January 13, 2009

Should this gene detection firm enter the business of providing tests for the detection of genetic diseases? If so, how should it prioritize the tests it could develop? Purchase this case: http://harvardbusinessonline.hbsp.harvard.edu/... View Details
Keywords: Martha Lagace
  • 02 Sep 2014
  • First Look

First Look: September 2

and applied levels. First, the field will broaden its boundaries to include genetics and molecular neuroscience, each of which will provide important new insights into individual differences in decision making. Second, recent advances in... View Details
Keywords: Sean Silverthorne
  • 01 May 2007
  • First Look

First Look: May 1, 2007

equitable sharing of the benefits arising from the use of genetic resources. Although the treaty had been in effect for almost 15 years, progress was slow. CBD Executive Secretary Ahmed Djoghlaf needed to increase the participation of the... View Details
Keywords: Sean Silverthorne
  • 07 Oct 2014
  • First Look

First Look: October 7

money for these purposes. In 2014, the MMRF was in the midst of its CoMMpass program; a multi-year effort to collect tissue samples from 1,000 patients at key junctures in their disease, sequence these samples to better understand the View Details
Keywords: Sean Silverthorne
  • 05 Sep 2017
  • First Look

First Look at New Research and Ideas, September 5, 2017

Harvard Business School Case 212-077 Maxum Petroleum, Inc. No abstract available. Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/212077-PDF-ENG Harvard Business School Case 517-129 23andMe: Genetic Testing for Consumers (C)... View Details
Keywords: Sean Silverthorne
  • 19 May 2009
  • First Look

First Look: May 19, 2009

several proof-of-concept tests and for which Rey foresaw a clear market in nutritional supplements and functional foods. The case provides context on the company; describes advances in crops genetics focused to climate change and... View Details
Keywords: Martha Lagace
  • 04 Jun 2007
  • Research & Ideas

Is Health Care Making You Better—or Dead?

can unravel the genetic code, we can measure tau neutrinos, but nope, the quality of this doctor or hospital is unmeasurable? I think these are very self-serving arguments. Q: Well, you almost automatically get transparency if you have... View Details
Keywords: by Sean Silverthorne; Health
  • May 2018
  • Case

The Multiple Myeloma Research Foundation's Answer Fund

By: Richard G. Hamermesh and Matthew G. Preble
Keywords: Data Analytics; Customer Focus and Relationships; Customer Relationship Management; Cost vs Benefits; Investment Return; Health Care and Treatment; Innovation Leadership; Intellectual Property; Knowledge Sharing; Knowledge Dissemination; Leadership; Leading Change; Resource Allocation; Goals and Objectives; Marketing Communications; Performance; Programs; Projects; Business and Community Relations; Business and Stakeholder Relations; Networks; Partners and Partnerships; Research and Development; Genetics; Behavior; Motivation and Incentives; Social and Collaborative Networks; Nonprofit Organizations; Strategy; Health Industry; Pharmaceutical Industry; Biotechnology Industry; United States
Related
  • 01 Feb 2011
  • First Look

First Look: Feb. 1

Biosciences: Seeds of Change (Abridged) Arthur A. Daemmrich, Forest Reinhardt, and Mary ShelmanHarvard Business School Case 711-050 Arcadia Biosciences is seeking to introduce genetically modified rice to China that will lower farmers'... View Details
  • 03 Mar 2009
  • First Look

First Look: March 3, 2009

prenatal screening for genetic diseases and DNA tests to determine lineage and paternity. In addition, the company launched a wholly-owned subsidiary, the Stem Cell Company. CEO Robert Jansen hoped to grow the Stem Cell Company but faced... View Details
Keywords: Martha Lagace
  • 30 May 2000
  • Research & Ideas

Market Makers Bid for Success

priority. But at FairMarket, we really don't teach anyone. You just throw folks in because you don't have the time. Start-ups are great places. You have to desire a start-up—almost from a genetic standpoint. Certainly I fit in that camp.... View Details
Keywords: by Staff; Web Services; Technology

Are you looking for?

→Search All HBS Web